Tin tức & Cập nhật

A single injection of intralesional botulinum toxin (BTX) demonstrates long-term efficacy and is well tolerated in patients with nail psoriasis, according to a randomized intraindividual controlled study presented at the recent WCD 2023. BTX is also as effective as multiple intralesional steroid injections.

The anti-interleukin (IL)-36 receptor monoclonal antibody spesolimab not only helps treat generalized pustular psoriasis (GPP) flares but also prevent them, according to the results of the Effisayil 2 study presented at WCD 2023.

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Individuals with Lynch syndrome (LS) often develop skin neoplasms, reports a recent study, which has identified several clinical factors that contribute to LS- and non-LS-related skin neoplasms.

Several cutaneous toxicities arising from ibrutinib therapy are similar to those caused by the use of selective epidermal growth factor receptor (EGFR) inhibitors, except for petechiae, according to a study.

The combination of camrelizumab plus apatinib and temozolomide appears to be beneficial in the first-line treatment of advanced acral melanoma, with the majority of the patients showing response and an acceptable safety profile, according to the results of a phase II study.